Performance Assessment of the BluePoint MycoID Plus Kit for Identification of Mycobacterium tuberculosis, Including Rifampin- and Isoniazid-resistant Isolates, and Nontuberculous Mycobacteria

The performance of the BluePoint MycoID plus kit (Bio Concept Corporation, Taichung, Taiwan), which was designed to simultaneously detect Mycobacterium tuberculosis (MTB), rifampin- and isoniazid-resistant MTB, and nontuberculous mycobacteria (NTM) was first evaluated with 950 consecutive positive c...

Descripción completa

Detalles Bibliográficos
Autores principales: Chien, Jung-Yien, Chang, Tsung-Chain, Chiu, Wei-Yih, Yu, Chong-Jen, Hsueh, Po-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418609/
https://www.ncbi.nlm.nih.gov/pubmed/25938668
http://dx.doi.org/10.1371/journal.pone.0125016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418609/
https://www.ncbi.nlm.nih.gov/pubmed/25938668
http://dx.doi.org/10.1371/journal.pone.0125016

Ejemplares similares